Report cover image

Saudi Arabia Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

Publisher Mordor Intelligence Inc
Published Aug 13, 2025
Length 80 Pages
SKU # MOI20474294

Description

Saudi Arabia Ophthalmic Devices Market Analysis

The Saudi Arabia ophthalmic devices market size is valued at USD 0.58 billion in 2025 and is forecast to reach USD 0.77 billion by 2030, registering a 5.76% CAGR. This advance is anchored in Vision 2030’s USD 65 billion healthcare-modernization plan. Sustained demand arises from a diabetes burden that climbed to 7 million cases in 2021 and is expected to hit 8.4 million by 2030, heightening the need for screening and monitoring technologies. Rapid adoption of artificial-intelligence (AI) diagnostics, growing private investment in ambulatory eye-care centers, and the emergence of Riyadh and Jeddah as medical-tourism hubs further energize the Saudi Arabia ophthalmic devices market. Headwinds persist, however, in the form of import dependency that raises device prices and a shortage of certified technicians, which limits throughput despite equipment availability. Policymakers are therefore refining Saudi Food and Drug Authority (SFDA) procedures and funding training pipelines to ease these constraints.

Saudi Arabia Ophthalmic Devices Market Trends and Insights

Government-Funded Vision 2030 Ophthalmology Infrastructure Expansion

Vision 2030 seeks to raise private-sector participation in healthcare to 68% by 2030 and add about 84,000 beds to reach OECD standards. Expansion plans by large hospital groups—such as Dr Sulaiman Al Habib Medical Services, which intends to grow capacity from 1,913 to 3,609 beds by 2028—translate directly into higher purchases of surgical microscopes, optical-coherence-tomography (OCT) scanners, and tele-ophthalmology platforms. The SEHA Virtual Hospital now links more than 150 hospitals, enabling remote retinal assessments and extending specialist reach.

High Diabetes Prevalence Driving AI-Based Diabetic-Retinopathy Screening Uptake

Diabetes affects 31.0% of adults in the Kingdom, and diabetic retinopathy (DR) impacts 46% of diabetics in the Western region. An AI-enabled national tele-retinopathy programme launched in 2024 accelerates screening throughput and accuracy. Early results indicate a 30.0% reduction in unnecessary referrals, spurring demand for AI-ready fundus cameras and cloud-integrated image-management systems. Persistent knowledge gaps—29% of patients report never having had an eye exam—are addressed by payer-funded awareness drives that should boost device utilisation.

Import Dependence Inflating Device Prices

The SFDA mandates ISO 13485 certification and local Authorised Representatives, raising import-transaction costs. Beginning January 2025, all medical devices also require SABER platform conformity certificates, which add compliance fees that sellers pass through to buyers. These expenses elevate landed costs—particularly for premium imaging equipment—by an estimated 15%, dampening uptake in smaller clinics.

Other drivers and restraints analyzed in the detailed report include:

  1. Compulsory Premarital & School Eye-Health Screening Programmes
  2. Rise of Premium Elective LASIK & Cataract Surgeries Via Medical-Tourism Hubs
  3. Shortage of Certified Ophthalmic Technicians Limiting Diagnostic Throughput

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Vision care devices retained a 60.41% share of the Saudi Arabia ophthalmic devices market in 2024, supported by steady demand for spectacles, contact lenses, and dispensing systems. Diagnostic & Monitoring Devices, however, are set to expand at a 7.86% CAGR through 2030, reflecting hospitals’ shift toward early-stage disease identification. Within this cluster, optical-coherence-tomography scanners should command 24.42% of diagnostic revenue in 2024, benefiting from superior retinal-layer visualisation that aids macular-degeneration and diabetic-retinopathy screening. Ultra-wide-field fundus cameras also post strong orders because clinicians want comprehensive peripheral-retina images to detect lesions missed by 45-degree systems.

The diagnostic up-cycle is reinforced by national tele-health mandates that integrate cloud-based image management and AI grading. As a result, the Saudi Arabia ophthalmic devices market size allocated to diagnostic hardware rises in tandem with digitally linked screening programmes. Surgical-device demand grows at a moderate clip, buoyed by premium intra-ocular-lens adoption in elective cataract and refractive procedures popular in Riyadh and Jeddah. Import tariffs remain a drag on smaller buyers, but multinational suppliers offset duties with leasing options and bundled-service contracts.

The Saudi Arabia Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, and Other Disease Indication), End User (Hospitals, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

List of Companies Covered in this Report:

  1. Alcon
  2. Bausch Health
  3. Carl Zeiss
  4. Johnson & Johnson Vision Care
  5. EssilorLuxottica
  6. NIDEK Co Ltd
  7. Topcon Corp
  8. HAAG-Streit
  9. Glaukos Corp
  10. CooperVision Inc
  11. STAAR Surgical
  12. Lumibird Medical
  13. Oculus Optikgerte GmbH
  14. Reichert Technologies
  15. BVI Medical

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

80 Pages
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Government-Funded Vision 2030 Ophthalmology Infrastructure Expansion
4.2.2 High Diabetes Prevalence Driving AI-Based Diabetic-Retinopathy Screening Uptake
4.2.3 Compulsory Pre-Marital & School Eye-Health Screening Programmes
4.2.4 Rise of Premium Elective LASIK & Cataract Surgeries Via Medical-Tourism Hubs (Riyadh, Jeddah)
4.2.5 Emergence of Public-Private Ophthalmic Centres of Excellence Under NHC PPP Model
4.2.6 Rapid Adoption of Cloud-Connected OCT & Fundus Cameras in Primary-Care Polyclinics
4.3 Market Restraints
4.3.1 Import-Dependence Inflating Device Prices Post-Tariff Harmonisation (SFDA)
4.3.2 Shortage of Certified Ophthalmic Technicians Limiting Diagnostic Throughput
4.3.3 Lengthy SFDA Device-Registration Timelines Delaying Launches
4.3.4 Price-Sensitive Contact-Lens E-Commerce Dampening Uptake of Premium Vision-Care Devices
4.4 Regulatory Outlook
4.5 Porter's Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitutes
4.5.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 OCT Scanners
5.1.1.2 Fundus & Retinal Cameras
5.1.1.3 Autorefractors & Keratometers
5.1.1.4 Corneal Topography Systems
5.1.1.5 Ultrasound Imaging Systems
5.1.1.6 Perimeters & Tonometers
5.1.1.7 Other Diagnostic & Monitoring Devices
5.1.2 Surgical Devices
5.1.2.1 Cataract Surgical Devices
5.1.2.2 Vitreoretinal Surgical Devices
5.1.2.3 Refreactive Surgical Devices
5.1.2.4 Glaucoma Surgical Devices
5.1.2.5 Other Surgical Devices
5.1.3 Vision Care Devices
5.1.3.1 Spectacles Frames & Lenses
5.1.3.2 Contact Lenses
5.2 By Disease Indication
5.2.1 Cataract
5.2.2 Glaucoma
5.2.3 Diabetic Retinopathy
5.2.4 Other Disease Indications
5.3 By End-user
5.3.1 Hospitals
5.3.2 Specialty Ophthalmic Clinics
5.3.3 Ambulatory Surgery Centers (ASCs)
5.3.4 Other End-users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Alcon Inc
6.3.2 Bausch Health Companies Inc
6.3.3 Carl Zeiss Meditec AG
6.3.4 Johnson & Johnson Vision Care
6.3.5 EssilorLuxottica SA
6.3.6 NIDEK Co Ltd
6.3.7 Topcon Corp
6.3.8 HAAG-Streit Group
6.3.9 Glaukos Corp
6.3.10 CooperVision Inc
6.3.11 STAAR Surgical
6.3.12 Lumibird Medical
6.3.13 Oculus Optikgerte GmbH
6.3.14 Reichert Technologies
6.3.15 BVI Medical
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us